FDA Approved: GEMFIBROZIL — Original Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for Gemfibrozil from XLCare Pharmaceuticals, granting approval for a generic version of the lipid-lowering drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Lipoprotein Metabolism
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

ORIG AP for GEMFIBROZIL (GEMFIBROZIL)